Company profile

AlphaThera

Simple, fast, site-specific antibody conjugation

Industry
Biotechnology Research
Employees
13
Headquarters
Philadelphia, Pennsylvania
Founded
2016
LinkedIn followers
1,594
Office locations
1

AlphaThera company summary

AlphaThera is a company in the Biotechnology Research industry, headquartered in Philadelphia, Pennsylvania, founded in 2016. On LinkedIn the company has around 13 employees and 1,594 followers. Its listed specialties include Antibody Conjugations, Site-Specific Conjugations, Rapid Conjugations, oYo-Link, Fluorescent Labels.

What technology does AlphaThera use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About AlphaThera

AlphaThera is a US based biotechnology company specializing in antibody labeling reagents. The company developed a unique, site-specific bioconjugation method that enhances assay performance over competing labeling methods. The company was founded by Dr Andrew Tsourkas and Dr. James Hui at the University of Pennsylvania in 2016. They developed the technology of LASIC (Light Assisted Site-specific Conjugation), which led to the creation of oYo-Link® antibody labeling reagents. oYo-Link® reagents enable rapid, covalent, site-specific antibody labeling to a wide range of cargos (e.g. biotin, azide, oligos, fluorescent proteins and more) in just 2 steps - mix and illuminate. Conjugation requires less than 30 seconds hands-on time, and is complete in 2 hours. Unlike other labeling technologies available commercially, no antibody purification is required, as oYo-Link is compatible with all common buffers, including those containing BSA, Tris and Azide, so researchers save valuable time and materials. Furthermore, oYo-Link enables conjugation with as little as 1µg of antibody at concentrations as low as 50µg/mL. AlphaThera's also provides Conjugation Services to researchers that would prefer to outsource their antibody conjugation. AlphaThera’s mission is to remove the complexity and inconsistency that has long been associated with antibody conjugations, making labeling simple, fast and site-specific.

Specialties

Antibody ConjugationsSite-Specific ConjugationsRapid ConjugationsoYo-LinkFluorescent LabelsOligonucleotidesAntibodyBioconjugationAntibodiesCustom ServicesAntibody LabelingResearchAntibody Drug ConjugatesClick ChemistryBiotin LabelingEpitope Tagsimmunoassays

Where is AlphaThera located?

AlphaThera lists 1 location.

Philadelphia, Pennsylvania, USHQ
3675 Market St

Compare companies similar to AlphaThera

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
AlphaThera
alphathera.com
Biotechnology Research132016Philadelphia, Pennsylvania
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about AlphaThera

What does AlphaThera do?

AlphaThera is a US based biotechnology company specializing in antibody labeling reagents. The company developed a unique, site-specific bioconjugation method that enhances assay performance over competing labeling methods. The company was founded by Dr Andrew Tsourkas and Dr. James Hui at the University of Pennsylvania in 2016. They developed the technology of LASIC (Light Assisted Site-specific Conjugation), which led to the creation of oYo-Link® antibody labeling reagents. oYo-Link® reagents enable rapid, covalent, site-specific antibody labeling to a wide range of cargos (e.g. biotin, azide, oligos, fluorescent proteins and more) in just 2 steps - mix and illuminate. Conjugation requires less than 30 seconds hands-on time, and is complete in 2 hours. Unlike other labeling technologies available commercially, no antibody purification is required, as oYo-Link is compatible with all common buffers, including those containing BSA, Tris and Azide, so researchers save valuable time and materials. Furthermore, oYo-Link enables conjugation with as little as 1µg of antibody at concentrations as low as 50µg/mL. AlphaThera's also provides Conjugation Services to researchers that would prefer to outsource their antibody conjugation. AlphaThera’s mission is to remove the complexity and inconsistency that has long been associated with antibody conjugations, making labeling simple, fast and site-specific.

How many employees does AlphaThera have?

AlphaThera has around 13 employees on LinkedIn.

Where is AlphaThera headquartered?

AlphaThera is headquartered in Philadelphia, Pennsylvania.

When was AlphaThera founded?

AlphaThera was founded in 2016.

Build a lead list from companies like AlphaThera

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.